EFSD/Sanofi European Diabetes Research Programme in Diabetes associated with Cardiovascular Disease

2023

Ben Arpad Kappel: RWTH Aachen University Hospital - Germany
Network analysis of interactome dysregulation in the pathogenesis of HFpEF in type 2 diabetes

Marleen van Greevenbroek: Maastricht University - Netherlands
Resolving cardiovascular risk in type 2 diabetes

2022

Massimo Federici: University of Rome Tor Vergata - Italy
3-hydroxisobutyrate: a bridge between diabetes and atherosclerotic macrovascular disease?

Casper G. Schalkwijk: Maastricht University Medical Center and Cardiovascular Research Institute Maastricht (CARIM) - Netherlands
DNA glycation by methylglyoxal: a novel mechanism and target of cardiovascular disease in diabetes

Daniel R. Witte: Steno Diabetes Center Aarhus - Denmark
Cardiovascular autonomic neuropathy, heart disease, and glucose variability in diabetes